• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 2 Company
  • 2.1 Philosophy
  • 2.2 Facts and Figures
  • 2.3 Management Board
  • 2.4 History
  • 2.5 Merz Pharmaceuticals
    • 2.5.1 Pharmaceutical Products
    • 2.5.2 International Presence
    • 2.5.3 Partners
    • 2.5.4 Awards
    • 2.5.5 Research Prizes Awarded
    • 2.5.6 Future Forum for Dementia
  • 2.6 Merz Consumer Care
  • 2.7 Merz Dental
  • 2.8 Merz Hygiene
  • 2.9 Merz Pharma Group
  • 2.10 Locations

Awards

The achievements of our employees have resulted in multiple awards for the Company in the past few years. We believe that awards are above all an incentive for consistently continuing a successful development. We know our work on behalf of people suffering from disease can give them back some hope and quality of life.

Innovation Prize of German Industry

On January 19, 2002, Merz Pharma KGaA received the 22nd Innovation Prize of German Industry from the Federal Minister for Research and Education, Edelgard Bulmahn. The prize honored Merz Pharma’s trendsetting research efforts in studying the innovative mechanism of action of Memantine as an NMDA antagonist.

H.G. Creutzfeldt Pharmaceutical Prize

In 2001, Merz received the H.G. Creutzfeldt Pharmaceutical Prize for its product Amantadine for the treatment of Parkinson’s disease. The prize is awarded annually by the Creutzfeldt-Institut of Kiel, Germany, and is intended to honor drugs that have been proven for both acute and long-term therapy for some time and combine well with other drugs. Other criteria in awarding the prize are safety, tolerance, and cost-effectiveness.

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

Broschures

• Merz Annual Reports

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s

Quick-Links